Pomegranate Compound Breaks Down Heart Disease Proteins

A compound hiding in pomegranate leaves might hold the key to treating a devastating disease that attacks the heart and nerves.

Researchers at Kumamoto University in Japan tested extracts from over 1,500 different plants, searching for something that could break apart the toxic protein tangles causing transthyretin amyloidosis. This progressive disease happens when a transport protein in the body misfolds and clumps together, forming deposits that damage organs. Current treatments can slow the disease by preventing new protein tangles from forming, but they can't undo damage that's already there.

The pomegranate extract stood out immediately. Compounds from the leaves and branches of the fruit powerfully disrupted the protein clumps that had already formed. The team identified the active ingredient as PGG, a molecule with five galloyl groups attached to a glucose core.

In laboratory tests, PGG successfully broke down protein tangles from both mutant and normal versions of the transthyretin protein. Even more impressive, it left other types of protein clumps alone, including those linked to Alzheimer's disease. This selectivity suggests the compound targets specific problem proteins without causing collateral damage.

The researchers then tested PGG in tiny worms engineered to develop the same protein deposits humans get. Treated worms lived longer, stayed healthier, and had fewer protein clumps in their bodies. The team even tested the compound on actual amyloid fibrils taken from a patient's heart tissue. PGG broke those apart too.

The Bright Side

Most treatments for protein-clumping diseases focus on prevention, like putting up sandbags before a flood. This discovery offers something different: a way to clean up after the flood has already happened. For patients who already have protein deposits damaging their organs, that distinction could be life-changing.

The structural analysis revealed why PGG works so well. Those multiple galloyl groups act like molecular crowbars, prying apart the tightly wound protein fibers. Understanding this mechanism gives scientists a blueprint for designing even better treatments.

The compound still needs safety testing in humans before it can become a medicine. But the research points toward a promising new strategy: using plant-derived molecules to actively remove the toxic deposits that drive disease, not just prevent new ones from forming.

Nature has been creating complex molecules for millions of years, and we're still discovering what they can do.